Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended	6 Months Ended
Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenues
Operating expenses
Research and development	350,442	2,295,251	596,067	4,885,896
General and administrative	459,223	744,617	1,117,135	1,301,509
Total operating expenses	809,665	3,039,868	1,713,202	6,187,405
Loss from operations	(809,665)	(3,039,868)	(1,713,202)	(6,187,405)
Other expenses
Change in fair value of warrant liability	10,785	1,270,202	48,096	707,284
Interest income	15,147	428	15,403	984
Total other income (expenses)	25,932	1,270,630	63,499	708,268
Net Loss	$ (783,733)	$ (1,769,238)	$ (1,649,703)	$ (5,479,137)
Weighted average shares outstanding - basic	1,168,423	339,308	915,931	295,031
Weighted average shares outstanding - diluted	1,168,423	339,308	915,931	295,031
Loss per share - basic	$ 0.67	$ (5.21)	$ (1.80)	$ (18.57)
Loss per share - diluted	$ 0.67	$ (5.21)	$ (1.80)	$ (18.57)

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.